ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
111.96
-0.61
( -0.54% )
Updated: 11:20:47

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
111.96
Bid
-
Ask
-
Volume
518,048
111.93 Day's Range 113.05
72.00 52 Week Range 119.59
Market Cap
Previous Close
112.57
Open
112.57
Last Trade
49
@
111.9501
Last Trade Time
11:20:48
Financial Volume
$ 58,298,402
VWAP
112.5348
Average Volume (3m)
2,811,612
Shares Outstanding
599,854,853
Dividend Yield
0.77%
PE Ratio
35.04
Earnings Per Share (EPS)
3.21
Revenue
12.55B
Net Profit
1.93B

About Amphenol Corp

Amphenol is a global supplier of connectors, sensors, and interconnect systems. Amphenol holds the second-largest connector market share globally and sells into the end markets of automotive, broadband, commercial air, industrial, IT and data communications, military, mobile devices, and mobile netw... Amphenol is a global supplier of connectors, sensors, and interconnect systems. Amphenol holds the second-largest connector market share globally and sells into the end markets of automotive, broadband, commercial air, industrial, IT and data communications, military, mobile devices, and mobile networks. Amphenol is diversified geographically, with operations in 40 countries. Show more

Sector
Electronic Connectors
Industry
Electronic Connectors
Headquarters
Wilmington, Delaware, USA
Founded
1970
Amphenol Corp is listed in the Electronic Connectors sector of the New York Stock Exchange with ticker APH. The last closing price for Amphenol was $112.57. Over the last year, Amphenol shares have traded in a share price range of $ 72.00 to $ 119.59.

Amphenol currently has 599,854,853 shares outstanding. The market capitalization of Amphenol is $67.55 billion. Amphenol has a price to earnings ratio (PE ratio) of 35.04.

Amphenol (APH) Options Flow Summary

Overall Flow

Bullish

Net Premium

272k

Calls / Puts

100.00%

Buys / Sells

300.00%

OTM / ITM

33.33%

Sweeps Ratio

0.00%

APH Latest News

Amphenol Corporation Announces Pricing of Senior Notes Offering

Amphenol Corporation (NYSE: APH) announced today the pricing of its offering of $450 million aggregate principal amount of senior notes due 2027 (the “2027 Notes”), $450 million aggregate...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.58-1.39158005989113.54116.18111.573294217113.84991312CS
40.930.837611456363111.03119.59110.8253371283114.6333007CS
1212.0312.038426898899.93119.5998.752811612109.41238641CS
2629.0835.086872586982.88119.5978.68274650599.57847714CS
5234.0243.64896073977.94119.5972266708090.77110132CS
15643.5363.612450679568.43119.5961.67244861080.32878956CS
2607.687.36478711162104.28138.258.58208997585.31379995CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
INVOINVO BioScience Inc
$ 2.785
(266.45%)
137.31M
EDBLEdible Garden AG Inc
$ 8.50
(86.81%)
8.79M
SINTSiNtx Technologies Inc
$ 0.0421
(83.84%)
204.97M
SPECSpectaire Holdings Inc
$ 1.2599
(57.51%)
12.79M
AWINAERWINS Technologies Inc
$ 4.675
(41.67%)
1.97M
IZMICZOOM Group Inc
$ 7.18
(-85.93%)
7.31M
SBFMSunshine Biopharma Inc
$ 3.995
(-41.25%)
2.77M
DAREDare Bioscience Inc
$ 0.3122
(-35.62%)
2.25M
LGVNLongeveron Inc
$ 2.42
(-31.44%)
1.83M
ISUNiSun Inc
$ 0.1555
(-25.95%)
997.58k
SINTSiNtx Technologies Inc
$ 0.0421
(83.84%)
204.97M
INVOINVO BioScience Inc
$ 2.785
(266.45%)
137.31M
JAGXJaguar Health Inc
$ 0.153
(-14.19%)
104.52M
SQQQProShares UltraPro Short QQQ
$ 11.58
(1.22%)
50.42M
WISAWiSA Technologies Inc
$ 7.17
(17.54%)
43.39M

APH Discussion

View Posts
Monksdream Monksdream 1 month ago
APH new 52 week high
👍️0
Monksdream Monksdream 2 months ago
APH new 52 week high
👍️0
Saving Grace Saving Grace 2 months ago
No doubt. Nice Hit!
👍️0
Monksdream Monksdream 2 months ago
APH new 52 week high
👍️0
Saving Grace Saving Grace 1 year ago
Amphenol Interconnect Products Corp., suspected sabotage of LMC parts.

First 19 recalled from a faulty connector and now a faulty washer on the brake caliper.

3 strikes and you're out is the message to Amphenol Interconnect Products Corp from shareholders of LMC.

Two different products in a month.

With Rivian Recall of 200,000 and Ford recalling 1.5 million EV's makes one wonder if EV's are under attack by big oil.
👍️0
$Pistol Pete$ $Pistol Pete$ 3 years ago
$APH $68.64
👍️0
whytestocks whytestocks 5 years ago
News: $APH Why Amphenol Stock Climbed 10.2% Last Month

Shares of Amphenol   (NYSE: APH) climbed 10.2% in September, according to data from  S&P Global Market Intelligence . The stock benefited from momentum for the broader market and the publication of research reports that boded well for the company's outlook in industrial sensors.&...

Find out more APH - Why Amphenol Stock Climbed 10.2% Last Month
👍️0
GreenKnight GreenKnight 6 years ago
BlindJohn - known ya since back in 2014 when all this took root! Remember You from SL especially. I hope all is well and that you have prospered SUPREMELY on all of your plays in this sector!

Take care! Remember "Blind Melon Chitlin" from Cheech and Chong LOL:




APH has been so good to us....and as a global player APH will be a force to be reckoned with my friend. Been holding BIG here all the way along. Take care and all best wishes for the New Year!
Gk
👍️0
Mt69sinai Mt69sinai 7 years ago
Aphria continues to be a BEAST almost everyday lately!!!
+.19/+.2.7% to finish the day at $7.31!!!
Looking for many more green days in advance of quarterly results on Fri Oct 13th
Over 5 consecutive quarters of positive earnings and #6 next week IMO!
Aphria top 50 TSX stocks of 2017 to own and top 30 IHUB boards of 2017 to be on with 0% negative posts and 100% positive posts.
$8 holla definately around the corner... Maybe before quarterly results if not definately after quarterly results with pps $8+
Glta
$APH$
👍️0
Mt69sinai Mt69sinai 7 years ago
APH finished the week GREEN!! UP +.26/+3.8% with a closing pps of $7.12!!
This is a 5 month high!!... And expect many more green days ahead of next earnings report in several weeks.
APH had 5 consecutive quarters of exceptional earnings and continue higher growth each quarter,,,, expecting between $8-$9+ after financials IMO and near 10+ by years end..
With legalization taking place in Canada around the second week of July 2018 I expect IMO a pps around $14+
Glta
$APH$
👍️0
Mt69sinai Mt69sinai 7 years ago
APH finished the day +.14/+2.1% to close at $6.81!!!
Looking good into financials coming up in October.
APH has had at least the past 5 quarters-record quarter$ and this quarter coming up will be no different IMO.
With legalization in Canada happening around the second week in July 2018 I expect pps to be in excess of $14+ by then,,, an easy double from here.
Glta
$APH$
👍️0
Mt69sinai Mt69sinai 7 years ago
APH up +.38 +6.3% to close the day at $6.38!! MJ sector is currently booming and lots of very green days ahead IMO especially in advance of Canada legalizing MJ by JULY 1st 2018!!
Glta
$APH$
👍️0
Mt69sinai Mt69sinai 7 years ago
APH> Due for a run any day now!!! Someone has been quietly accumulating in the $5.90-$6 range for many days now.
$APH$
👍️0
-Kush- -Kush- 7 years ago
Lol 2$
👍️0
Mt69sinai Mt69sinai 7 years ago
APH what a BEAST!!! Gap up tomorrow first thing then BOOM BOOM!!!
$APH$
👍️0
Mt69sinai Mt69sinai 7 years ago
EBITDA increases 181% in the quarter, exceeding $2.8 million

Cash costs to produce dried cannabis per gram decreases 35% from prior quarter

LEAMINGTON, ONTARIO – July 12, 2017 – Aphria Inc. (“Aphria” or the “Company”) (TSX: APH or USOTCQB: APHQF) today reported its results, for the fourth quarter and year ended May 31, 2017. All amounts are expressed in Canadian dollars.



Operating Highlights

• Seventh consecutive quarter of positive EBITDA. $2.8 million in EBITDA in the quarter, a 181% increase from the prior quarter, and $6.1 million for the year, a 962% increase year-over-year.

• Increased our annual production capacity expectations for Part II (to 9,000 kgs), Part III (to 30,000 kgs) & to Part IV (100,000 kgs) expansion projects.

• Received Health Canada approval for our Part II expansion. First harvest in the new expansion will occur in the middle of July. First sale, from the plants grown in the expansion, is expected in mid-August 2017 (late in Q1).

• Improved “all-in” costs to produce dried cannabis per gram from $2.23 to $1.67 in the quarter, a decrease of 25%.

• Improved cash costs to produce dried cannabis per gram from $1.73 to $1.11 in the quarter, a decrease of 36%, based on Aphria’s definition. Some of our competitors are using a definition different from Aphria’s for cash costs to produce. Applying their definition to our results, Aphria’s cash cost to produce per gram decreased from $1.42 to $0.79, a decrease of 44%.

• Exercised our conversion rights on the unsecured convertible debentures of SecureCom Mobile Inc.(“SecureCom”) in exchange for 4,000,000 shares and exercised our warrant, purchasing an additional 4,000,000 shares @ $0.08 per share bringing our total investment in SecureCom to 8,000,000 shares at a cost of $520,000. As at May 31, 2017, the fair value of the SecureCom shares was $1,664,000.

• Licensed the use of the Aphria Know-How System, as further detailed in the MD&A being filed concurrently with this release, to DFMMJ Investments, Ltd. (“DFMMJ”), in exchange for 192,400,000 shares in DFMMJ.

• Invested approximately $25 million in DFMMJ, which DFMMJ used, along with other monies raised via a private placement, to acquire all or substantially all of the assets of Chestnut Hill Tree Farm LLC, in exchange for in excess of 120,000,000 shares of DFMMJ, in addition to our existing DFMMJ shares.

• Received final approval to list on the Toronto Stock Exchange (“TSX”). Shares commenced trading on the TSX and were delisted from the TSX-Venture Exchange on March 22, 2017.

• Closed May bought deal and debt financing raising over $105 million in additional proceeds to fully fund our Part IV expansion project, fully fund our working capital needs after completion of the expansion project and raised funds for additional strategic investments.

“We capped off another exceptional year at Aphria, with increased earnings and lowered all-in production cash costs that provides us with a considerable competitive advantage,” said Vic Neufeld, Chief Executive Officer, Aphria. “We increased our capacity expectations, continued to license the use of the Aphria Know-How System to expand our proven operational expertise, made progress on our expansion into the US market – all while maintaining our commitment to delivering clean and safe cannabis. The investments and progress we made in 2017 have positioned Aphria for continued profitable growth, in both the short and long term.”

“As the medical marijuana industry rapidly expands, we believe there is a need to establish a consistent, responsible and transparent definition for licensed producers to calculate their costs to produce dried cannabis per gram. To ensure an accurate peer to peer comparison of this important metric, we are proposing the establishment of an industry standard definition for costs that includes all costs related to the production of cannabis, including quality control costs.”

Financial highlights

For the seventh consecutive quarter, the Company reported positive EBITDA. In the quarter, the Company reported $2.8 million in EBITDA, a 181% increase over the prior quarter and for the year ended May 31, 2017, reported $6.1 million in EBITDA, a 961% increase over the prior year. The Company remains committed to the responsible use of our shareholders’ investment in Aphria. The Company continues to invest in its recreational brand, continues to proceed diligently on its capital investment plans and continues to explore other opportunities to increase shareholder value, while ensuring appropriate liquidity risk mitigation strategies are in place.
Revenue for the three months ended May 31, 2017 was $5,717,866, representing a 11.7% increase over the prior quarter’s revenue of $5,188,516, in a quarter in which the Company was capacity constrained. The Company’s exceptional March and May harvests, along with its inventory levels, allowed the Company to sell more than its expected quarterly production of 650 kgs. Cannabis oil sales, as a percentage of all revenue, continued to grow in the quarter, increasing to 32% of revenue.

For the year ended May 31, 2017, revenue was $20,438,483 versus $8,433,929 in the year ended May 31, 2016, an increase of 142%.

Adjusted gross profit for the fourth quarter was $4,902,960 with an adjusted gross margin of 85.7%, generated from both retail and wholesale shipments of medical cannabis. The increase in the adjusted gross margin from the prior quarter is consistent with the increase in revenues combined with improved cost structures.

Adjusted gross profit for the year was $15,853,608, with an adjusted gross margin of 77.6%.

During the quarter, our “all-in” costs of dried cannabis per gram decreased from $2.23 to $1.67. The decrease largely related to improved growing techniques and better cooperation from Mother Nature. Similarly, our cash costs of dried cannabis per gram decreased from $1.73 to $1.11, using Aphria’s standard definition.

While the Company believes strongly in its definition of cash costs to produce dried cannabis per gram, certain of its publicly traded competitors are disclosing a similarly titled metric but for which they are using a different definition of cash costs. The primary differences between Aphria’s definition and certain competitors’ definition is that Aphria’s definition includes the costs related to indirect labour expenses and quality control costs. Aphria believes that both of these expenses should be included in any cash cost calculation. However, for the sole purpose of presenting a figure which is comparable to this other definition, we re-calculated our cash costs to produce dried cannabis per gram by deducting so-called post production costs from our cash cost to produce dried cannabis and divided that sum by gram equivalents sold in the quarter. Using this definition of cash costs to produce dried cannabis, Aphria’s fourth quarter figure is $0.79 per gram.

Net loss for the three months ended May 31, 2017 was $2,592,742 or $0.02 per share as opposed to a net income of $1,302,164 or $0.02 per share in the same quarter in the previous year and an income before tax of $4,950,250 or $0.04 per share in the previous quarter. The decrease in net income for Aphria in the quarter is directly related to the more than $5.5 million net loss on the Company’s strategic investments in the quarter.

Net income for the year ended May 31, 2017 was $4,198,455 or $0.04 per share versus net income of $397,961 or $0.01 in the prior year. Included in the net income for the 2017 year was a gain on the Company’s investment portfolio of almost $3.6 million and a write-off of the Company’s intangible asset, related to its CannWay brand, of $3.5 million.

EBITDA for the fourth quarter was $2,826,667, compared to an EBITDA of $520,685 in the same period of the prior year and EBITDA of $1,005,516 in the previous quarter.

EBITDA for the year ended May 31, 2017 was $6,082,546 compared to EBITDA of $572,888 in the prior year.

We have A Good Thing Growing.

1 – In this press release, reference is made to “all-in” costs to produce dried cannabis per gram, cash costs to produce dried cannabis, cash costs to produce dried cannabis per gram, adjusted gross profit, adjusted gross margin and EBITDA, which are not measures of financial performance under International Financial Reporting Standards. Definitions for all terms above can be found in the Company’s May 31, 2017 Management’s Discussion and Analysis, filed on SEDAR.

About Aphria
Aphria Inc., one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada. Aphria is truly powered by sunlight, allowing for the most natural growing conditions available. We are committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders. We are the first public licenced producer to report positive cash flow from operations and the first to report positive earnings in consecutive quarters.

For more information, visit www.aphria.com.

For further information please contact:
Nina Godard
Edelman
nina.godard@edelman.com
416-455-6324

Vic Neufeld
President & CEO
1-844-427-4742

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend” or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, statements with respect to internal expectations, estimated margins, expectations for future growing capacity and costs, the completion of any capital project or expansions, any commentary related to the legalization of cannabis and the timing related thereto, expectations of Health Canada approvals and expectations with respect to future production costs. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical cannabis or adult use of cannabis; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the medical cannabis industry in Canada generally, income tax and regulatory matters; the ability of Aphria to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

$APH$
👍️0
blindjohn blindjohn 8 years ago
Keep rising APH. Need you to be at $2.00 when $sprw f gets license so $SPrwf can hit $1.00 land
👍️0
blindjohn blindjohn 8 years ago
Boom
👍️0
Highlander2 Highlander2 9 years ago
Why the plummet today?
👍️0
brentkosta brentkosta 9 years ago
Looks like Aphria got another license. I bet that's why they suspended trading.
👍️0
WallWeeD WallWeeD 9 years ago
The company itself put a halt.. That is perfectly normal here in Canada.. Some kind of news are coming that is why
👍️0
Japple Japple 9 years ago
Seems this stock has been halted... Not that it traded anyway.
👍️0
Penny Roger$ Penny Roger$ 9 years ago
1.00 would be 5200% profit and you would need to sell here and stay the course right?
👍️0
chris12 chris12 9 years ago
THIS WILL MOVE BACK TO A-$1.00-NOW-AT-$52.33-HOLDING-FOR-100%-PROFIT-HERE-NO-BRAINER
👍️0
Penny Roger$ Penny Roger$ 12 years ago
Amphenol Corp. Announces Second Quarter 2012 Dividend Payment and Quarterly D...
Reuters Key Development - Apr 26, 2012

http://stocks.us.reuters.com/stocks/keyDevelopments.asp?rpc=66&symbol=APH×tamp=20120426120000
👍️0
Penny Roger$ Penny Roger$ 12 years ago
~ Wednesday! $APH ~ Q1 Earnings posted, pending or coming soon! In Charts and Links Below!

~ $APH ~ Earnings expected on Wednesday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=APH&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=APH&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=APH
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=APH#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=APH+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=APH
Finviz: http://finviz.com/quote.ashx?t=APH
~ BusyStock: http://busystock.com/i.php?s=APH&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=APH >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.
👍️0
Penny Roger$ Penny Roger$ 12 years ago
Amphenol Corporation (Amphenol) is a designer, manufacturer and marketer of electrical, electronic and fiber optic connectors, interconnect systems and coaxial and high-speed specialty cable. Amphenol designs and manufactures connectors and interconnect systems, which are used primarily to conduct electrical and optical signals for a range of electronic applications. It has developed a range of connector and interconnect products for information technology and communications equipment applications, including the converging voice, video and data communications markets. The Company offers a range of interconnect products for factory automation and motion control systems, machine tools, instrumentation and medical systems, mass transportation applications and automotive safety systems and a diverse range of on-board electronics. In addition, Amphenol is a supplier of high performance, military-specification, circular environmental connectors.

http://www.google.com/finance?q=APH
👍️0

Your Recent History

Delayed Upgrade Clock